Symmetric and asymmetric left ventricular hypertrophy in patients with end-stage renal failure on long-term hemodialysis

Clinical Cardiology

Volumn 21, Issue 9, 1998, Pages 672-678

  Straumann, Edwin ^a,b   Bertel, Osmund ^b   Meyer, Beat ^a   Weiss, Philip ^c   Misteli, Max ^a   Blumberg, Alfred ^a   Jenzer, Hansrudolf ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Age; Asymmetric hypertrophy; Body mass index; End stage renal disease; Hypertension; Left ventricular hypertrophy; Left ventricular outflow tract; Maintenance hemodialysis

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE;

EID: 0031663285     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960210913     Document Type: Article

References (27)

1. Cooper RS, Simmons BE, Castaner A: Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990;65:441-445
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli W: Prognostic implication of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322:1561-1566
4. Sullivan JM, Vander Zwaag RV, El Zecky F, Ramanathan KB, Mirvis DM: Left ventricular hypertrophy: Effect on survival. J Am Coll Cardiol 1993;22:508-513
5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47: 186-192
6. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ: Natural history of hypertensive cardiomyopathy in the elderly. J Am Coll Cardiol 1990;16:821-826
7. Pastan SO, Braunwald E: Renal disorders and heart disease. In Heart Disease, 4th ed. (Ed. Braunwald E), p. 1856-1874. Philadelphia: W.B. Saunders Company, 1992
8. Rhodes J, Schiller MS, Tejani A, Gonzalez R: Hemodialysis-induced subaortic obstruction in asymmetric septal hypertrophy. Am Heart J 1992;123:807-810
9. Straumann E, Meyer B, Misteli M, Blumberg A, Jenzer HR: Aortic and mitral valve disease in patients with end stage renal failure on long-term hemodialysis. Br Heart J 1992;67:236-239
10. Braunwald E: Valvular heart disease. In Heart Disease, 4th ed. (Ed. Braunwald E), p. 1018-1043. Philadelphia: W.B. Saunders Company, 1992
11. Feigenbaum H: The echocardiographic examination. In Echocardiography, 4th ed. (Ed. Feigenbaum H), p. 68-95. Philadelphia: Lea and Febiger, 1994
12. Devereux R, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57:450-458
13. Feigenbaum H: Calcified mitral annulus. In Echocardiography, 4th ed. (Ed. Feigenbaum H), p. 325-329. Philadelphia: Lea and Febiger, 1994
14. Altman DG: Practical Statistics for Medical Research, p. 336-352. London: Chapman and Hall, 1991
15. Siegel D, Cheitlin MD, Black DM: Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 1990;65:742-747
16. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG: Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-1114
17. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-789
18. Kenny J, McCarthy C, Blake S, McCann P, Counihan TB: Hypertrophic cardiomyopathy, ten years experience. Ir J Med Sci 1987; 56:56-60
19. Savage DD, Drayer JM, Henry WL, Mathews EC, Ware JH, Gardin JM, Cohen ER, Epstein SE, Larah JH: Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation 1979;59:623-632
20. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR: Aortic and mitral valve calcifications in patients with end stage renal disease. Lancet 1987;ii:875-877
21. Hüting J, Kramer W, Schutterle G, Wizemann V: Analysis of left ventricular changes associated with chronic hemodialysis. Nephron 1988;49:284-290
22. Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J: Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study. Clin Nephrol 1991;35:280-287
23. Messerli FA, Sundgaar-Riise K, Reisin ED, Dreslinski GR, Ventura HO, Ogiman W, Frohlich ED, Dunn FG: Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1993;99:757-761
24. Sasson Z, Rasooly Y, Bhesania T, Rasooly I: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88:1431-1436
25. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD: Age related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clinic Proc 1988;63:137-146
26. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE: Mutations in the genes for cardiac troponin t and -tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;322:1058-1064
27. Pearson AC, Gudipati CV, Labovitz A: Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;12:989-995